Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Researchers unravel how a breast cancer gene affects fertility
University of Oregon biologists have uncovered a mechanism by which a well-known breast cancer gene…
In beer yeast, scientists find potential path to starving cancer
The discovery of a surprising way yeast used to brew beer can survive starvation could…
New study suggests diet may lower risk of prostate cancer progression
A recent study highlights the link between diet and prostate cancer grade reclassification in men…
Radiopharmaceutical shows early promise in prostate cancer trial
- Black men more likely to have prostate cancer than white men at same PSA level
- ESMO 2023: Lutetium (177Lu) vipivotide tetraxetan shows clinically meaningful and highly statistically significant rPFS benefit in patients with PSMA-positive mCRPC in the pre-taxane setting
- Scientists reverse drug resistance in prostate cancer by targeting ‘hijacked’ white blood cells
Insights from our genome and epigenome will help prevent, diagnose and treat cancer
By Professor Susan Clark In 2020, an estimated 10 million people lost their lives to cancer. This devastating disease is…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.